Sign In
15 May 2018 14:26
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 15 May 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 15 May 2015 under the 2014 Executive Incentive Plan ("EIP") Element C which was completed on 15 May 2018. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the EIP is £nil.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Said Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Shares acquired from vesting of the conditional awards on15 May 2018 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 27,000 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 15 May 2018 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Mazen Darwazah
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Mazen Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Vice Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Shares acquired from vesting of the conditional awards on15 May 2018 under the 2014 EIP Element C. |
c) | Price(s) and volume(s) | Price(s): £nil Volume(s): 20,000 |
d) | Aggregated information | N/A |
e) | Date of the transaction | 15 May 2018 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Peter SpeirsCompany Secretary, responsible for releasing this announcement+44 (0) 20 7399 2760
Hikma Pharmaceuticals (HIK)
Follow the stocks
